Caitong International Asset Management Co., LTD Sutro Biopharma, Inc. Transaction History
Caitong International Asset Management Co., LTD
- $102 Billion
- Q4 2024
A detailed history of Caitong International Asset Management Co., LTD transactions in Sutro Biopharma, Inc. stock. As of the latest transaction made, Caitong International Asset Management Co., LTD holds 350 shares of STRO stock, worth $626. This represents 0.0% of its overall portfolio holdings.
Number of Shares
350
Previous 350
-0.0%
Holding current value
$626
Previous $644,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding STRO
# of Institutions
127Shares Held
59.9MCall Options Held
203KPut Options Held
33.6K-
Suvretta Capital Management, LLC New York, NY7.46MShares$13.4 Million0.57% of portfolio
-
Black Rock Inc. New York, NY6.91MShares$12.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.21MShares$7.53 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ3.64MShares$6.52 Million0.42% of portfolio
-
Vestal Point Capital, LP New York, NY2.57MShares$4.6 Million0.28% of portfolio
About SUTRO BIOPHARMA, INC.
- Ticker STRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,161,500
- Market Cap $93.4M
- Description
- Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...